Commercialising research: the collaboration between tech transfer and investment

In the tenth episode, Dr Anne Lane, CEO of UCLB and Dr Chris Hollowood, CEO of Syncona Investment Management, discussed the collaboration between their respective organisations in commercialising research. Syncona is a leading healthcare investment company focused on creating, building and scaling a portfolio of global leaders in life science; and Chris has been instrumental in the foundation and the development of its gene therapy strategy. In this podcast, Anne and Chris discussed how Syncona came about, its close relationship with UCL and UCL Business, and what attracted Syncona to invest in four UCLB companies. Chris also discussed the tech transfer ecosystem and what is next for Syncona. For more information and to access the transcript: www.uclb.com/event-category/podcast/ Date of episode recording: 2023-09-21 Duration: 00:30:11 Language of episode: English Presenter: Dr Anne Lane Guests: Dr Chris Hollowood Producer: Nora Amin

There are no comments yet.

Please log in to write the first comment.